[1] Nilius,B.,Watanabe, H.,Vriens,J.The TRPV4 channel:structure-function relationship and promiscuous gating behaviour.European Journal of Physiology (2003)446:298-303
[2] Nilius,B.,Vriens,J.Th., Prenen,J., Droogmans,G., Voets, T. TRPV4 calcium entry channel: a paradigm for gating diversity.(2004). American Journal of Physiology-Cell Physiology 286:C195-C205
[3] Ramsey IS, Delling M, Clapham DE. An introduction to trp channels.Annu Rev Physiol. 2006;68:619-47.
[4] Castillo-Davis, C.I., Hartl, D.L., Achaz,G.cis-Regulatory and protein evolution in orthologous and duplicate gens.(2004). Genome Research 14:1530-1536.
[5] Farré,D., Roset,R., Huerta, M., Aduara, J.E.,Roselló, L., Albà , M. M., Messeguer, X. Identification of patterns in biological sequences at the ALGGEN server:PROMO and MALGEN.((2003)Nucleic Acids Research 31:3651-3653.
[6] Wingender, E.,Chen, X., Hehl, R.,Karas, H., Liebich,I., Matys, V., Meinhardt, T., Pruss, M., Reuter, I., Schacherer, F.TRANSFAC: an integrated system for gene expression regulation.(2000) 28:316-319.
[7]Moriscot AS, Sayen MR, Hartong R, Wu P, Dillmann WH. Transcription of the Rat Sarcoplasmic Reticulum Ca2+ Adenosine Triphosphatase Gene Is Increased by 3,5,3'-Triiodothyronine Receptor Isoform-Specific Interactions with the Myocyte-Specific Enhancer Factor-2a1.Endocrinology. 1997 Jan;138(1):26-32.
[8] Yu YT, Breitbart RE, Smoot LB, Lee Y, Mahdavi V, Nadal-Ginard B.Human myocyte-specific enhancer factor 2 comprises a group of tissue- restricted MADS box transcription factors. Genes Dev. 1992 Sep;6(9):1783-98.
[9]Wang L, Fan C, Topol SE, Topol EJ, Wang Q.Mutation of MEF2A in an Inherited Disorder with Features of Coronary Artery DiseaseScience. 2003 Nov 28;302(5650):1578-81.
[10] Altshuler D, Hirschhorn JN. MEF2A sequence variants and coronary artery disease: a change of heart?J Clin Invest. 2005 Apr;115(4):831-3.
[11] Kino T, Vottero A, Charmandari E, Chrousos GP. Familial/sporadic glucocorticoid resistance syndrome and hypertension.Ann N Y Acad Sci. 2002 Sep;970:101-11. Review.
[12] Baid S, Nieman LK.Glucocorticoid excess and hypertension.Curr Hypertens Rep. 2004 Dec;6(6):493-9. Review.
[13]Garcia MA, Martin-Santamaria S, de Pascual-Teresa B, Ramos A, Julian M, Martinez A. Adrenomedullin: a new and promising target for drug discovery.
Expert Opin Ther Targets. 2006 Apr;10(2):303-17.
[14]Schmitz C, Perraud AL.The TRPM cation channels in the immune context.Curr Pharm Des. 2005;11(21):2765-78.
[15]The TRPM ion channels and their potential role in modulating the immune response.Mol Immunol. 2004 Jul;41(6-7):657-73. Review.
[16] Solway J, Forsythe SM, Halayko AJ, Vieira JE, Hershenson MB, Camoretti-Mercado B.Transcriptional regulation of smooth muscle contractile apparatus expression.Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 3):S100-8. Review.
[17]Liedtke W, Simon SA.A possible role for TRPV4 receptors in asthma.
Am J Physiol Lung Cell Mol Physiol. 2004 Aug;287(2):L269-71. Review.
[18] Nord M, Cassel TN, Braun H, Suske G.Regulation of the Clara cell secretory protein/uteroglobin promoter in lung.Ann N Y Acad Sci. 2000;923:154-65. Review.
